Clinical trials: Mass Spectrometry
Subarachnoid Hemorrhage, Aneurysmal, Cerebrocardiac Syndrome
Mechanisms of Brain-Heart Injury of Post-Intracranial Hemorrhage
Intracranial hemorrhage is a condition characterized by high mortality rates and suboptimal functional outcomes. It precipitates both direct brain injury and subsequent secondary injuries, including delayed cerebral ischemia…
- Conditions
- Subarachnoid Hemorrhage, Aneurysmal, Cerebrocardiac Syndrome, Mass Spectrometry, Heart Failure
- Trial name
- NCT06906432
- Testing
- Multi-disciplinary assessment
- Where
- China
- Volunteers
- 1,000 people, healthy volunteers welcome
- Sponsor
- Beijing Tiantan Hospital
Esophagus Adenocarcinoma, Esophagus Cancer
Oncometabolome and MALDI-MSI in Upper GI Carcinomas - Chemosensitivity in Esophageal Carcinoma
Locally advanced adenocarcinoma of the esophagus is a leading cause of death from malignant disease in Germany and has been characterized on a molecular level in recent years.
- Conditions
- Esophagus Adenocarcinoma, Esophagus Cancer, Metabolome, Mass Spectrometry
- Trial name
- NCT06642506
- Where
- Germany
- Volunteers
- 20 people
- Sponsor
- Ludwig-Maximilians - University of Munich
Exhaled Breath, Mass Spectrometry
Breath Analysis in Healthy Controls
The purpose of this study is to detect a specific profile of breath in healthy subjects by an untargeted metabolomic study using exhaled breath analysis by mass spectrometry.
- Conditions
- Exhaled Breath, Mass Spectrometry, Healthy Subjects
- Trial name
- NCT02595632
- Testing
- No intervention
- Where
- Switzerland
- Volunteers
- 183 people, healthy volunteers welcome
- Sponsor
- University of Zurich
Obstructive Sleep Apnoea (OSA), Exhaled Breath
Mass Spectral Fingerprinting in Obstructive Sleep Apnoea
To answer the question whether a previously detected breath profile in patients suffering from obstructive sleep apnoea (OSA) can be found in a cohort of patients with suspected OSA using mass spectrometry (validation study).
- Conditions
- Obstructive Sleep Apnoea (OSA), Exhaled Breath, Mass Spectrometry
- Trial name
- NCT02810158
- Where
- Switzerland
- Volunteers
- 150 people
- Sponsor
- University of Zurich
Colorectal Cancer, Drug Resistance
The Emergence of RAS Mutations in Metastatic Colorectal Cancer Patients Receiving Cetuximab Treatment
To evaluate the emergence of RAS mutation in patients with metastatic colorectal cancer, circulating free DNA will be analyzed using mass spectrometric genotyping in subjects during cetuximab treatment.
- Conditions
- Colorectal Cancer, Drug Resistance, Mass Spectrometry, RAS-RAF Pathway Deregulation
- Trial name
- NCT03401957
- Testing
- Cetuximab, liquid biopsy
- Where
- 4 sites in Taiwan
- Volunteers
- 120 people
- Sponsor
- National Health Research Institutes, Taiwan
Asthma, Exhaled Breath
Breath Analysis in Asthma
The purpose of this study is to answer the question whether a disease-specific profile of breath in patients with asthma can be detected by an untargeted metabolomic study using exhaled breath analysis by mass spectrometry.
- Conditions
- Asthma, Exhaled Breath, Mass Spectrometry
- Trial name
- NCT02450461
- Testing
- no intervention
- Where
- Switzerland
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- University of Zurich